Anthracyclines are among the most active drugs in breast cancer patients. We planned to
evaluate the early and 2-year modification of left ventricular ejection fraction (LVEF) and the …

Background B‐type natriuretic peptide (BNP) is a marker for heart failure (HF) severity, but
its association with hospital readmission is not well defined. Methods and Results We …

Abstract Background: The Doppler echocardiographic restrictive mitral filling pattern (RFP) is
an important prognostic indicator in patients with heart failure (HF), but the interaction …

Advanced cardiovascular interventions and an aging population contribute to the growing
prevalence of patients with heart failure (HF). Improved medical management, while …

Bisoprolol fumarate (bisoprolol) is a β-blocker widely used to treat chronic heart failure
(CHF). However, few studies have compared its efficacy and safety with those of the widely …

Background Endothelial dysfunction (ED), a well-established risk marker of cardiovascular
events, is associated with heart failure (HF) and atrial fibrillation (AF). Its relationship with …

Galectin-3 demonstrated to be a robust independent marker of cardiovascular mid-term (18-
month) outcome in heart failure (HF) patients. The objective of this study was to analyze the …

N-terminal pro-brain natriuretic peptide (NT–pro-BNP) and blood urea nitrogen (BUN)
predict outcomes in patients with heart failure (HF). However, it is unknown whether NT–pro …

BACKGROUND: Half of patients with acute heart failure syndromes (AHFS) have preserved
left ventricular ejection fraction (PLVEF). In this setting, the role of minor myocardial damage …

BACKGROUND: Brain natriuretic peptide (BNP) is increasingly used in the management of
patients with heart failure (HF). It is still unclear how to use serial BNP measurement in HF …